Summit Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Summit Financial's AMGN Position: Q2 2026 in Review
Summit Financial reduced its Amgen (AMGN) stake by 6.3% in Q2 2026, selling an estimated $445K and leaving 19,430 shares worth $7.04M. The position accounts for 0.08% of the portfolio, ranked #263.
Summit Financial first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $7.29M in Q1 2026. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Summit Financial held 19,430 shares of Amgen worth $7.04M as of Q2 2026.
- Summit Financial sold 1,301 Amgen shares in Q2 2026, an estimated $445K.
- Amgen made up 0.08% of Summit Financial's portfolio in Q2 2026, its #263 holding.
- Summit Financial first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
- Summit Financial's Amgen position peaked at $7.29M in Q1 2026.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.